Skip to Main Content
Directory of Faculty Research Interests
YSM Home

INFORMATION FOR

Frank Giordano, MD

Associate Professor of Medicine (Cardiology)

Contact Information

Frank Giordano, MD

Mailing Address

  • Cardiovascular Medicine

    PO Box 208056, 333 Cedar Street

    New Haven, CT 06520-8056

    United States

Yale Medicine

Patient Care

Are you a patient?Please visit the Yale Medicine website for information about the services we offer and making an appointment.View Doctor Profile

Research Summary

Dr. Frank Giordano has been studying myocardial angiogenesis, evaluating the consequences of deletion or over-expression of pro-angiogenic genes in animal models. He has been working on the development of new viral vectors for gene delivery, in ongoing assessments of cardiovascular gene therapy. Dr. Giordano is leading the efforts to develop a viral vector core at Yale. Dr. Kerry Russell studies signaling pathways induced by growth factors of the neuregulin family, and their erbB receptors, and the effect of activation on vascular form and function.

Specialized Terms: Myocardial angiogenesis; Viral vectors

Coauthors

Research Interests

Cardiology; Myocardial Ischemia; Receptors, Vascular Endothelial Growth Factor

Selected Publications

  • A Remote Role for RenalaseGiordano FJ, Wang Y, Desir GV. A Remote Role for Renalase. EBioMedicine 2016, 9: 27-28. PMID: 27374133, PMCID: PMC4972559, DOI: 10.1016/j.ebiom.2016.06.034.
  • Blood pressure changes and pharmacokinetics following vascular endothelial growth factor (rhVEGF) infusion in humans (In preparation).Eppler SM, McCluskey ER, Bloedow DC, Henry TD, Simons M, Giordano FJ, Zioncheck TF. Blood pressure changes and pharmacokinetics following vascular endothelial growth factor (rhVEGF) infusion in humans (In preparation).
  • INK4B gene expression induces apoptosis in vascular smooth muscle cells and morphometric changes in cardiac myocytes and skeletal myoblasts (In preparation)Giordano FJ, Katragadda R, Rothman A, Lu C-Y: INK4B gene expression induces apoptosis in vascular smooth muscle cells and morphometric changes in cardiac myocytes and skeletal myoblasts (In preparation).
  • Infusion of VEGF by Intracoronary or Intravenous Route Ameliorates Ischemia Induced Contractile Abnormalities in the Pig (In preparation).Giordano FJ, Ross Jr J, Peterson KL, Dalton N, McCluskey T, Zionchek T, McKirnan MD: Infusion of VEGF by Intracoronary or Intravenous Route Ameliorates Ischemia Induced Contractile Abnormalities in the Pig (In preparation).
  • Intravenous administration of recombinant human vascular endothelial growth factor (rhVEGF) in patients with ischemic heart disease (In preparation).Simons M, Giordano FJ, Henry TD, Powell JS, Azrin MA, Kereiakes DJ, Annex B, Miller JM, Gibson CM, Lewin HC, Berman DS, McCluskey ER: Intravenous administration of recombinant human vascular endothelial growth factor (rhVEGF) in patients with ischemic heart disease (In preparation).
Edit Profile